BioMarin Pharmaceuticals BMRN Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's common stock, shares, outstanding?
- BioMarin Pharmaceuticals (BMRN) reported common stock, shares, outstanding of $193.27M in Q1 2026.
- How has BioMarin Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- BioMarin Pharmaceuticals's common stock, shares, outstanding increased by 0.8% year-over-year, from $191.76M to $193.27M.
- What is the long-term trend for BioMarin Pharmaceuticals's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's common stock, shares, outstanding has grown at a 1.1% compound annual growth rate (CAGR), from $181.74M to $192.3M.